Literature DB >> 361794

Response to corticosteroids in chronic bronchitis.

C Shim, D E Stover, M H Williams.   

Abstract

Corticosteroid drugs are often employed in the treatment of patients with chronic bronchitis. Although some patients respond favorably to such therapy, the characteristics of such patients are not known. Twenty-four patients with chronic bronchitis were treated with prednisone 30 mg daily or placebo for one week each in a double-blind crossover study. The following were monitored before and after each treatment period: physical examination, symptoms, peripheral blood eosinophil count, sputum cell exmination, forced vital capacity (FVC), before and after isoproterenol aerosol. Seven of 24 patients had an FEV1 increase greater than 30% of the control value on prednisone but not on placebo. Blood eosinophil count was elevated (greater than or equal to 350/mm(3)) in 7 patients; 2 of these 7 improved on steroid. Sputum cell examination revealed preponderance of eosinophils in 1, and occasional clumps of eosinophils in 8. Seven of these 9 responded to steroid. Sputum but not blood eosinophilia is a good predictor of a favorable response to steroid therapy.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 361794     DOI: 10.1016/0091-6749(78)90137-9

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  14 in total

1.  Effects of inhaled budesonide on spirometric values, reversibility, airway responsiveness, and cough threshold in smokers with chronic obstructive lung disease.

Authors:  B Auffarth; D S Postma; J G de Monchy; T W van der Mark; M Boorsma; G H Koëter
Journal:  Thorax       Date:  1991-05       Impact factor: 9.139

2.  Corticosteroids in stable chronic obstructive pulmonary disease: reappraisal of efficacy.

Authors:  J K Stoller; Z B Gerbarg; A R Feinstein
Journal:  J Gen Intern Med       Date:  1987 Jan-Feb       Impact factor: 5.128

Review 3.  Management of chronic obstructive pulmonary disease.

Authors:  S Kesten; A S Rebuck
Journal:  Drugs       Date:  1989-07       Impact factor: 9.546

4.  Predicting sputum eosinophilia in exacerbations of COPD using exhaled nitric oxide.

Authors:  Szabolcs Soter; Imre Barta; Balazs Antus
Journal:  Inflammation       Date:  2013-10       Impact factor: 4.092

Review 5.  Chronic obstructive pulmonary disease.

Authors:  N R Anthonisen
Journal:  CMAJ       Date:  1988-03-15       Impact factor: 8.262

6.  Effect of oral prednisolone on response to salbutamol and ipratropium bromide aerosols in patients with chronic airflow obstruction.

Authors:  P G Curzon; M A Martin; N J Cooke; M F Muers
Journal:  Thorax       Date:  1983-08       Impact factor: 9.139

7.  Bronchial responsiveness, lung mechanics, gas transfer, and corticosteroid response in patients with chronic airflow obstruction.

Authors:  A L James; K E Finucane; G Ryan; A W Musk
Journal:  Thorax       Date:  1988-11       Impact factor: 9.139

8.  Effects of corticosteroids on bronchodilator action in chronic obstructive lung disease.

Authors:  J B Wempe; D S Postma; N Breederveld; E Kort; T W van der Mark; G H Koëter
Journal:  Thorax       Date:  1992-08       Impact factor: 9.139

9.  Effects of high dose inhaled beclomethasone dipropionate, 750 micrograms and 1500 micrograms twice daily, and 40 mg per day oral prednisolone on lung function, symptoms, and bronchial hyperresponsiveness in patients with non-asthmatic chronic airflow obstruction.

Authors:  D C Weir; P S Burge
Journal:  Thorax       Date:  1993-04       Impact factor: 9.139

10.  Psychological changes and improvement in chronic airflow limitation after corticosteroid treatment.

Authors:  D M Mitchell; P Gildeh; M Rehahn; A Dimond; J V Collins
Journal:  Thorax       Date:  1984-12       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.